Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Arkansas Children's Research Institute, Little Rock, AR, USA.
Aliment Pharmacol Ther. 2018 Mar;47(6):738-752. doi: 10.1111/apt.14519. Epub 2018 Jan 26.
BACKGROUND: Peppermint oil has been used for centuries as a treatment for gastrointestinal ailments. It has been shown to have several effects on gastrointestinal physiology relevant to clinical care and management. AIM: To review the literature on peppermint oil regarding its metabolism, effects on gastrointestinal physiology, clinical use and efficacy, and safety. METHODS: We performed a PubMed literature search using the following terms individually or in combination: peppermint, peppermint oil, pharmacokinetics, menthol, oesophagus, stomach, small intestine, gallbladder, colon, transit, dyspepsia, nausea, abdominal pain, and irritable bowel syndrome. Full manuscripts evaluating peppermint oil that were published through 15 July 2017 were reviewed. When evaluating therapeutic indications, only randomised clinical trials were included. References from selected manuscripts were used if relevant. RESULTS: It appears that peppermint oil may have several mechanisms of action including: smooth muscle relaxation (via calcium channel blockade or direct enteric nervous system effects); visceral sensitivity modulation (via transient receptor potential cation channels); anti-microbial effects; anti-inflammatory activity; modulation of psychosocial distress. Peppermint oil has been found to affect oesophageal, gastric, small bowel, gall-bladder, and colonic physiology. It has been used to facilitate completion of colonoscopy and endoscopic retrograde cholangiopancreatography. Placebo controlled studies support its use in irritable bowel syndrome, functional dyspepsia, childhood functional abdominal pain, and post-operative nausea. Few adverse effects have been reported in peppermint oil trials. CONCLUSION: Peppermint oil is a natural product which affects physiology throughout the gastrointestinal tract, has been used successfully for several clinical disorders, and appears to have a good safety profile.
背景:薄荷油作为一种治疗胃肠道疾病的药物已经使用了几个世纪。它对胃肠道生理学有多种影响,与临床护理和管理有关。
目的:综述薄荷油在代谢、胃肠道生理学作用、临床应用和疗效、安全性方面的文献。
方法:我们使用以下术语进行了 PubMed 文献检索,单独或组合使用:薄荷、薄荷油、药代动力学、薄荷醇、食管、胃、小肠、胆囊、结肠、转运、消化不良、恶心、腹痛和肠易激综合征。评估薄荷油的全文文献均通过 2017 年 7 月 15 日发表,进行了审查。在评估治疗指征时,仅纳入随机临床试验。如果相关,还使用了选定手稿的参考文献。
结果:薄荷油可能具有多种作用机制,包括:平滑肌松弛(通过钙通道阻断或直接肠神经系统作用);内脏敏感性调节(通过瞬时受体电位阳离子通道);抗菌作用;抗炎活性;调节心理社会困扰。薄荷油已被发现可影响食管、胃、小肠、胆囊和结肠的生理学。它已被用于促进结肠镜检查和内镜逆行胰胆管造影的完成。安慰剂对照研究支持其在肠易激综合征、功能性消化不良、儿童功能性腹痛和术后恶心中的应用。薄荷油试验中报告的不良反应很少。
结论:薄荷油是一种天然产物,可影响胃肠道的生理学,已成功用于多种临床疾病,且似乎具有良好的安全性。
Curr Pharm Des. 2023
J Clin Gastroenterol. 2014-7
United European Gastroenterol J. 2021-11
Am Fam Physician. 2007-4-1
Aliment Pharmacol Ther. 2022-9
Pharmaceuticals (Basel). 2025-5-8
Plants (Basel). 2024-12-16
J Neurogastroenterol Motil. 2024-10-30
Eur J Pharmacol. 2017-3-18
Front Pharmacol. 2016-6-17
Food Microbiol. 2015-8-18
Eur J Pharmacol. 2014-7-18